VALENTINO, FRANCESCO
VALENTINO, FRANCESCO
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value
2021-01-01 Cosentino, G.; Avenali, M.; Schindler, A.; Pizzorni, N.; Montomoli, C.; Abbruzzese, G.; Antonini, A.; Barbiera, F.; Benazzo, M.; Benarroch, E. E.; Bertino, G.; Cereda, E.; Clave, P.; Cortelli, P.; Eleopra, R.; Ferrari, C.; Hamdy, S.; Huckabee, M. -L.; Lopiano, L.; Marchese Ragona, R.; Masiero, S.; Michou, E.; Occhini, A.; Pacchetti, C.; Pfeiffer, R. F.; Restivo, D. A.; Rondanelli, M.; Ruoppolo, G.; Sandrini, G.; Schapira, A. H. V.; Stocchi, F.; Tolosa, E.; Valentino, F.; Zamboni, M.; Zangaglia, R.; Zappia, M.; Tassorelli, C.; Alfonsi, E.
Chemoresistance as a function of the pre-therapy tumor burden and the chemotherapy regimen administered. Differences observed with two current chemotherapy regimens for advanced Hodgkin lymphoma
2011-01-01 Gobbi, Paolo; Valentino, Francesco; Bassi, E.; Coriani, C.; Merli, F.; Bonfante, V.; Marchianò, A.; Gallamini, A.; Bolis, S.; Stelitano, C.; Levis, A.; Federico, M.; Angrilli, F.; Di Giulio, G.; Corazza, GINO ROBERTO
Chemoresistance as a function of the pretherapy tumor burden and the chemotherapy regimen administered: differences observed with 2 current chemotherapy regimens for advanced Hodgkin lymphoma.
2011-01-01 Gobbi, PIER GIORGIO; Valentino, Francesco; Bassi, E; Coriani, C; Merli, F; Bonfante, V; Marchianò, A; Gallamini, A; Bolis, S; Stelitano, C; Levis, A; Federico, M; Angrilli, F; Di Giulio, G; Corazza, GINO ROBERTO
Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy.
2009-01-01 Gobbi, PIER GIORGIO; Corbella, F; Valentino, Francesco; Bergonzi, M; Sangalli, C; Perfetti, V; Corazza, GINO ROBERTO
Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy.
2009-01-01 Gobbi, Paolo; Corbella, F; Valentino, Francesco; Bergonzi, M; Sangalli, C; Perfetti, V; Corazza, GINO ROBERTO
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
2006-01-01 Gobbi, PIER GIORGIO; Broglia, C; Levis, A; La Sala, A; Valentino, Francesco; Chisesi, T; Sacchi, S; Corbella, F; Cavanna, L; Iannitto, E; Pavone, V; Molica, S; Corazza, GINO ROBERTO; Federico, M.
New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer.
2008-01-01 Gobbi, Paolo; Valentino, Francesco; Berardi, Eliana; Tronconi, C; Brugnatelli, Silvia; Luinetti, Ombretta; Moratti, Remigio; Corazza, GINO ROBERTO
New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer.
2008-01-01 Gobbi, PIER GIORGIO; Valentino, Francesco; Berardi, E; Tronconi, C; Brugnatelli, S; Luinetti, O; Moratti, R; Corazza, GINO ROBERTO
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy].
2006-01-01 Broglia, CHIARA MARIA GIOVANNA; Merlati, Giuseppe; Valentino, Francesco; Benatti, Chiara; Gobbi, Paolo; Ascari, Edoardo
Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs.
2009-01-01 Gobbi, PIER GIORGIO; Valentino, Francesco; Lambelet, P; Perfetti, V; Bergamaschi, Gaetano; Girino, M; Corazza, GINO ROBERTO
Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs.
2009-01-01 Gobbi, Paolo; Valentino, Francesco; Lambelet, P; Perfetti, V; Bergamaschi, Gaetano; Girino, M; Corazza, GINO ROBERTO
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL).
2006-01-01 Gobbi, PIER GIORGIO; Broglia, C; Valentino, Francesco; Mammi, C; Lombardo, M; Merli, F; Luminari, S; Polimeno, G; Riezzo, A; Lambelet, P; Rovati, A; Corazza, GINO ROBERTO; Federico, M; Gruppo Italiano Studio, Linfomi
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value | 1-gen-2021 | Cosentino, G.; Avenali, M.; Schindler, A.; Pizzorni, N.; Montomoli, C.; Abbruzzese, G.; Antonini, A.; Barbiera, F.; Benazzo, M.; Benarroch, E. E.; Bertino, G.; Cereda, E.; Clave, P.; Cortelli, P.; Eleopra, R.; Ferrari, C.; Hamdy, S.; Huckabee, M. -L.; Lopiano, L.; Marchese Ragona, R.; Masiero, S.; Michou, E.; Occhini, A.; Pacchetti, C.; Pfeiffer, R. F.; Restivo, D. A.; Rondanelli, M.; Ruoppolo, G.; Sandrini, G.; Schapira, A. H. V.; Stocchi, F.; Tolosa, E.; Valentino, F.; Zamboni, M.; Zangaglia, R.; Zappia, M.; Tassorelli, C.; Alfonsi, E. | |
| Chemoresistance as a function of the pre-therapy tumor burden and the chemotherapy regimen administered. Differences observed with two current chemotherapy regimens for advanced Hodgkin lymphoma | 1-gen-2011 | Gobbi, Paolo; Valentino, Francesco; Bassi, E.; Coriani, C.; Merli, F.; Bonfante, V.; Marchianò, A.; Gallamini, A.; Bolis, S.; Stelitano, C.; Levis, A.; Federico, M.; Angrilli, F.; Di Giulio, G.; Corazza, GINO ROBERTO | |
| Chemoresistance as a function of the pretherapy tumor burden and the chemotherapy regimen administered: differences observed with 2 current chemotherapy regimens for advanced Hodgkin lymphoma. | 1-gen-2011 | Gobbi, PIER GIORGIO; Valentino, Francesco; Bassi, E; Coriani, C; Merli, F; Bonfante, V; Marchianò, A; Gallamini, A; Bolis, S; Stelitano, C; Levis, A; Federico, M; Angrilli, F; Di Giulio, G; Corazza, GINO ROBERTO | |
| Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. | 1-gen-2009 | Gobbi, PIER GIORGIO; Corbella, F; Valentino, Francesco; Bergonzi, M; Sangalli, C; Perfetti, V; Corazza, GINO ROBERTO | |
| Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. | 1-gen-2009 | Gobbi, Paolo; Corbella, F; Valentino, Francesco; Bergonzi, M; Sangalli, C; Perfetti, V; Corazza, GINO ROBERTO | |
| MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. | 1-gen-2006 | Gobbi, PIER GIORGIO; Broglia, C; Levis, A; La Sala, A; Valentino, Francesco; Chisesi, T; Sacchi, S; Corbella, F; Cavanna, L; Iannitto, E; Pavone, V; Molica, S; Corazza, GINO ROBERTO; Federico, M. | |
| New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. | 1-gen-2008 | Gobbi, Paolo; Valentino, Francesco; Berardi, Eliana; Tronconi, C; Brugnatelli, Silvia; Luinetti, Ombretta; Moratti, Remigio; Corazza, GINO ROBERTO | |
| New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. | 1-gen-2008 | Gobbi, PIER GIORGIO; Valentino, Francesco; Berardi, E; Tronconi, C; Brugnatelli, S; Luinetti, O; Moratti, R; Corazza, GINO ROBERTO | |
| Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. | 1-gen-2006 | Broglia, CHIARA MARIA GIOVANNA; Merlati, Giuseppe; Valentino, Francesco; Benatti, Chiara; Gobbi, Paolo; Ascari, Edoardo | |
| Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. | 1-gen-2009 | Gobbi, PIER GIORGIO; Valentino, Francesco; Lambelet, P; Perfetti, V; Bergamaschi, Gaetano; Girino, M; Corazza, GINO ROBERTO | |
| Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. | 1-gen-2009 | Gobbi, Paolo; Valentino, Francesco; Lambelet, P; Perfetti, V; Bergamaschi, Gaetano; Girino, M; Corazza, GINO ROBERTO | |
| The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL). | 1-gen-2006 | Gobbi, PIER GIORGIO; Broglia, C; Valentino, Francesco; Mammi, C; Lombardo, M; Merli, F; Luminari, S; Polimeno, G; Riezzo, A; Lambelet, P; Rovati, A; Corazza, GINO ROBERTO; Federico, M; Gruppo Italiano Studio, Linfomi |